Eric M. Dube, CEO: Travere Therapeutics TVTX Planned sale · Filed 25/10/28

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Eric M. DubeCEO
Planned sale date: 25/10/28
Filed: 25/10/28

0.1% of shares outstanding to be sold

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/28~25/11/27

Eric M. Dube's recent trades

Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.9M
108,493 sh
$6.9M
Filed 09/17
Traded 09/17
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$12.2M
195,841 sh
$12.2M
Filed 09/16
Traded 09/16
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
95,666 sh
$6.3M
Filed 09/15
Traded 09/15
Eric M. DubeCEO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06

Eric M. Dube, CEO — plans to sell 92,872 sh of Travere Therapeutics TVTX · $2.8M · around 10/28 · 10b5-1 plan | Whalegun